Commentary

Clarifying a statement about efficacy of FGA, SGA


 

References

We appreciate Dr. Nasrallah referencing our work to assert that “most SGAs are similar to FGAs.” (Current Psychiatry, Comments & Controversies, October 2013, p. 39-40; http://bit.ly/177QOy6). What we actually found in our 20031 and 20112 meta-analyses was that “some antipsychotics are more efficacious than others,” and the first-generation antipsychotic vs second-generation antipsychotic distinction is not very useful clinically.3 These findings have repeatedly been replicated.3

John M. Davis, MD
Professor
Department of Psychiatry
University of Illinois at Chicago
Chicago, Illinoi
s

Ira D. Glick, MD
Professor Emeritus of Psychiatry and Behavioral Sciences
Department of Psychiatry
Stanford University School of Medicine
Stanford, California

Recommended Reading

CMS: Projected overall growth rate in health spending holding firm
MDedge Psychiatry
Congress sends opioid legislation to the President
MDedge Psychiatry
Use simple algorithms to manage dementia
MDedge Psychiatry
PTSD, eating disorders tied to suppressing negative emotions
MDedge Psychiatry
Cost of end-of-life care peaks at age 73 years
MDedge Psychiatry
Common surgeries linked to chronic opioid use among opioid-naive patients
MDedge Psychiatry
Supreme Court offers mixed take on false claim liability
MDedge Psychiatry
Buprenorphine implants rival daily sublingual buprenorphine for opioid dependence
MDedge Psychiatry
Anxiety predicts cognitive decline and dementia
MDedge Psychiatry
Indiana HIV outbreak linked to injection use of oxymorphone
MDedge Psychiatry

Related Articles